Go Pro
NASDAQ:YI

111 Q1 2025 Earnings Report

111 logo
$3.82 +0.23 (+6.27%)
As of 03:20 PM Eastern
This is a fair market value price provided by Massive. Learn more.

111 EPS Results

Actual EPS
-$0.20
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

111 Revenue Results

Actual Revenue
$486.35 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

111 Announcement Details

Quarter
Q1 2025
Time
Before Market Opens
Conference Call Date
Friday, June 20, 2025
Conference Call Time
12:00AM ET

Upcoming Earnings

111's Q3 2026 earnings is estimated for Thursday, November 26, 2026, based on past reporting schedules

Earnings Documents

111 Earnings Headlines

111 (NASDAQ:YI) Announces Earnings Results
Head-To-Head Analysis: SBC Medical Group (NASDAQ:SBC) & 111 (NASDAQ:YI)
The end may be near for these iconic stocks
Marc Chaikin, founder of Chaikin Analytics, says two forces - AI disruption and fracturing global trade - are triggering a historic wealth transfer already underway in 2026. Household names like Intuit (-57%), Boston Scientific (-49%), and Tractor Supply (-40%) are cratering, while lesser-known companies like Sandisk (+573%) and Rackspace (+444%) surge. Chaikin has identified specific stocks he believes investors should sell before they fall further - and the names may surprise you. He's also pinpointing a company tapped as Nvidia's self-driving partner and a potential AI megadeal that could split into three high-growth stocks. Stream his free presentation to get every buy and sell recommendation with no membership or credit card required.tc pixel
111, Inc Q2 Loss Widens From Lower Revenue; Shares Up
See More 111 Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like 111? Sign up for Earnings360's daily newsletter to receive timely earnings updates on 111 and other key companies, straight to your email.

About 111

111 (NASDAQ:YI), Inc. is a China-based digital healthcare company that operates an online platform connecting consumers, pharmacies, hospitals, pharmaceutical manufacturers and other healthcare participants. The company focuses on improving access to medicines and healthcare products through technology-enabled distribution and retail services.

Its business includes online sales and distribution of prescription and over-the-counter medicines, medical devices, nutritional products and other healthcare merchandise. 111 also provides business-to-business services that help pharmacies and medical institutions source products, manage inventory and access digital tools, while its consumer-facing operations offer online medicine and healthcare product purchasing.

Founded in 2010 and headquartered in Shanghai, 111 primarily serves the Chinese market. The company was established by Junling Liu, who has served as its chief executive officer and chairman. Its American depositary shares trade on the Nasdaq Global Market under the symbol YI.

View 111 Profile